InvestorPlace - Stock Market News, Stock Advice & Trading Tips
With production ramping to 1.4 billion doses and next-gen vaccine in trials, don’t underestimate Covid-19 vaccine upside for MRNA stock.
The post Covid-19 Vaccine Orders Are Piling Up, Moderna Stock Has Room to Grow appeared first on InvestorPlace.
More From InvestorPlace